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The importance of the phospholipase A2 domain located within the unique N terminus of the capsid viral protein VP1 (VP1u) in
parvovirus infection has been reported. This study used computational methods to characterize the VP1 sequence for adeno-
associated virus (AAV) serotypes 1 to 12 and circular dichroism and electron microscopy to monitor conformational changes in
the AAV1 capsid induced by temperature and the pHs encountered during trafficking through the endocytic pathway. Circular
dichroism was also used to monitor conformational changes in AAV6 capsids assembled from VP2 and VP3 or VP1, VP2, and
VP3 at pH 7.5. VP1u was predicted (computationally) and confirmed (in solution) to be structurally ordered. This VP domain
was observed to undergo a reversible pH-induced unfolding/refolding process, a loss/gain of -helical structure, which did not
disrupt the capsid integrity and is likely facilitated by its difference in isoelectric point compared to the other VP sequences as-
sembling the capsid. This study is the first to physically document conformational changes in the VP1u region that likely facili-
tate its externalization from the capsid interior during infection and establishes the order of events in the escape of the AAV cap-
sid from the endosome en route to the nucleus.
Adeno-associated viruses (AAVs) are nonpathogenic membersof the Parvoviridae family, belong to the Dependovirus genus,
and require helper functions from viruses such as Adenovirus or
Herpesvirus for infection (1–4). Twelve distinct AAV serotypes
and over 100 genome isolates have been reported (5–7). Consid-
erable interest has been generated in their development as gene
delivery vectors, and numerous studies show that each virus has
unique cellular transduction characteristics (5, 8–13). Recent suc-
cesses in AAV gene delivery, including the treatment of blindness
using AAV2 (14), highlight the clinical potential of these vectors
and generated a considerable amount of media and public interest
in the use of AAV vectors. However, many key questions remain to
be answered about the basic biology of these viruses during infec-
tion, including the role of capsid viral protein (VP) transitions
that enable infection. Understanding such processes can aid de-
velopment of more-efficacious forms of the AAVs as vectors for
gene delivery.
The AAVs package a genome of 4.7 kb in an icosahedral
capsid (T  1), assembled from 60 capsid VP monomers, with a
diameter of 260 Å. The capsid is comprised of three VPs: VP1,
VP2, and VP3. VP1 contains the entire VP2 sequence in addition
to a unique 137-amino-acid N-terminal region (VP1u), while
the VP2 protein contains the entire VP3 sequence in addition to
an 65-amino-acid N-terminal region (VP1/2 common region).
VP3 is the major capsid protein, accounting for approximately 50
of the 60 capsid monomers, while there are approximately 5 copies
each of VP1 and VP2 (and thus a ratio of 1:1:10 for VP1:VP2:VP3)
per capsid as determined by gel densitometry studies (15–17). The
three-dimensional structures for several AAV serotypes including
AAV1, AAV2, AAV3b, AAV4, AAV5, AAV6, AAV7, AAV8, and
AAV9 have been determined by cryoelectron microscopy (cryo-
EM) and image reconstruction and/or by X-ray crystallography
(18–26, 71).
The structure of only the common C-terminal VP3 region
(530 residues) is known in atomic detail. Cryo-EM studies of
AAV1, AAV2, and AAV4 capsids identified density “globules” lo-
cated in the interior of the capsid beneath the icosahedral 2-fold
axis, which have been interpreted as the N-terminal regions of
VP1 and VP2 (23, 27, 28), but the structural topology of these
regions remains to be elucidated. In crystal structures, the loca-
tions of VP1u, the VP1/2 common region, and the first 15 resi-
dues of VP3 have not been observed. This is proposed to be due
either to low copy numbers of VP1 and VP2 in the capsids or to the
possibility that the N termini of VP1, VP2, and VP3 adopt differ-
ent conformations in the capsid. These properties are incompati-
ble with the icosahedral symmetry assumed during structure de-
termination.
The structural topology of the common AAV VP3 region is
highly conserved. It consists of a core eight-stranded antiparallel
-barrel (designated B-I) with an additional -strand A (A)
that forms the contiguous capsid shell, while loop insertions be-
tween the strands form the majority of the capsid surface (Fig. 1A).
The loops contain small stretches of helical and -strand structure
as well as variable regions (VRs, as defined in reference 71) when
different AAV structures are compared. The major capsid surface
features include depressions at the icosahedral 2-fold symmetry
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axis and surrounding the 5-fold axis and protrusions surrounding
the 3-fold axes (Fig. 1B). A conserved -helix (A, residues 294 to
303; AAV1 VP1 numbering) forms the wall of the 2-fold depres-
sion (Fig. 1A). The 3-fold protrusions are formed from intertwin-
ing loops from 3-fold symmetry-related VP3 monomers and are
the most variable regions within parvovirus capsids with respect
to sequence and structure. Two small stretches of -strand
structure, between D and E, form a radial -ribbon at the
5-fold icosahedral axis (Fig. 1A). Five such ribbons form a
conserved cylindrical channel connecting the interior to the
exterior of the capsid (Fig. 1B). A structurally conserved loop
between H and I (HI loop) (Fig. 1A) forms the most exten-
sive 5-fold related VP contacts and lies on the depression sur-
rounding the channel (Fig. 1B).
The infectious pathway of the AAV is initiated by the attach-
ment of the virus to the cell surface by binding to a primary glycan
receptor (11, 13, 29–35). This is followed by interactions with
membrane-bound coreceptors, for example, fibroblast growth
factor receptor and V5 and 51 integrin receptors for AAV2
(36–38), platelet-derived growth factor receptor for AAV5 (39),
and the 37-/67-kDa laminin receptor for AAV8 (40). Following
attachment, the endocytosis of the capsid has been reported to
occur by means of clathrin-coated pits (41), though recent studies
have described a clathrin-independent mechanism (42). After en-
docytosis, the virus traffics through the endocytic pathway and
accumulates in the perinuclear region (43) before delivering its
infective genome to the nucleus. However, the exact mechanism
of endosomal escape and nuclear entry remains to be fully eluci-
dated. It has been reported that shortly after entering the early
endosome, the N termini of VP1 and VP2 become externalized on
the capsid surface while the capsid remains assembled (44). It is
known that VP1u contains a phospholipase A2 domain (PLA2)
and two nuclear localization signals (NLSs) that modify the endo-
somal membranes to enable escape and targeting to the nucleus,
respectively. Genetic studies show that both PLA2 and NLS are
necessary for efficient infection (44–48). It is also known that the
acidic environment of the endosome is essential for virus infec-
tion, as inhibitors of the vacuolar H-ATPases such as bafilomy-
cin A1 and treatment of cells with NH4Cl both inhibit AAV trans-
duction and reduce trafficking to the nucleus (49–53). However,
VP1u was not detected on the capsid surface after treatment of
particles with the acidic pHs (pH 5.0) of the endosome alone
(44). Therefore, the exact trigger of VP1u externalization, which is
common to all parvoviruses, is unclear and requires further inves-
tigation.
In this study, computational and biophysical approaches were
used to characterize the structural features of the AAV VP1 in the
context of the capsid. The monomer sequence was analyzed to
identify possible regions of intrinsic disorder, and the isoelectric
point (pI) values of the three VP sequences, VP1, VP2, and VP3,
were calculated. The VP1u and VP3 common sequences were pre-
dicted to adopt a structured state, while the VP1/VP2 common
region displayed a high probability of being intrinsically disor-
dered. The pI value for VP1u was lower than that of the overall
capsid, suggesting differential susceptibility to environmental
conditions, such as those encountered in the endosome. Circular
dichroism (CD) confirmed that the VP1u in AAV1 and AAV6 has
an ordered -helical secondary structure in solution. This -heli-
cal structure was gradually lost with decrease in pH from 7.5 to 4.0
and was restored when the pH was returned to 7.5, highlighting a
transition likely associated with function. Negative-stain EM vi-
sualization showed that AAV1 capsids remain intact during pH
treatment, consistent with previous reports of structural integrity
for AAV8 capsids incubated at the pHs associated with the endo-
cytic pathway and characterized by X-ray crystallography (54).
This study is the first to physically document conformational
changes in the VP1u region and establishes the order of events in
the escape of the AAV capsid from the endosome en route to the
nucleus.
MATERIALS AND METHODS
VLP expression and purification. Sf9 cells infected with a baculovirus
construct containing the AAV1 cap gene, expressing VP1, VP2, and VP3,
was used to produce virus-like particles (VLPs) and purified as previously
reported (19). In addition, two types of AAV6 VLPs, assembled from VP2
and VP3 only or VP1, VP2, and VP3, were produced from a baculovirus
construct containing the AAV6 cap gene expressing VP2 and VP3 (22) or
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FIG 1 AAV1 structure. (A) Crystal structure of AAV1 capsid VP3 monomer
(PDB ID, 3NG9). The -strands are shown in purple ribbon, the conserved -
helix A is in red, and loops between the strands are in yellow. The dotted lines
show the relative positions of the 5-fold (filled pentagon), 3-fold (filled trian-
gle), and 2-fold (filled oval) interfaces of symmetry from the center of the
capsid. An eight-stranded -barrel (with -sheets CHEF and BIDG), along
with A (labeled) and -helix A (A), forms the core of the VP monomer
structure, flanked by large loop regions. The DE and HI loops (between
-strands D and E and between H and I, respectively) as well as the first
ordered N-terminal residue (218), the C-terminus, and the interior and exte-
rior capsid surfaces are labeled. (B) Radially color-cued (from capsid center to
surface, blue to green to yellow to red) surface representation of the AAV1
capsid. The white triangle depicts a viral asymmetric unit bounded by one
5-fold axis and two 3-fold axes with a 2-fold axis between them. The approx-
imate locations of the icosahedral 2-fold (2F), 3F, and 5F axes are indicated by
the black arrows. The positions of the DE and HI loops are indicated by the
dashed arrows. Images in panels A and B were generated using PyMol (DeLano
Scientific) and UCSF-Chimera (70), respectively.
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VP1 and a second construct containing the cap gene expressing VP2 and
VP3. Briefly, cells grown in Erlenmeyer flasks at 300 K using Sf-900 II SFM
medium (Gibco/Invitrogen Corporation) were infected with the respec-
tive baculovirus constructs at a multiplicity of infection of 5.0 PFU per
cell. The cells were lysed, 72 h postinfection, by three freeze-thaw cycles
with Benzonase added after the second cycle. The sample was centrifuged
at 12,100  g at 4°C for 15 min to separate the VLPs from the cell debris.
The VLPs were pelleted by sucrose cushion (20% [wt/vol] sucrose in 50
mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, and 0.2% Triton X-100)
centrifugation at 149,000  g at 4°C for 3 h. The pellet was further purified
by sucrose gradient (10 to 40% [wt/vol] sucrose in 25 mM Tris-HCl, 100
mM NaCl, 0.2% Triton X-100, and 2 mM MgCl2) centrifugation at
151,000  g at 4°C for 3 h. The sample purity and integrity were moni-
tored by 10% SDS-PAGE with Coomassie blue staining and electron mi-
croscopy (50,000), respectively, and the concentration was determined
using UV/visible light (Vis) spectrometry (260/280 nm; molar extinction
coefficient, 1.7 for concentration in mg/ml). The purified samples were
buffer exchanged into phosphate-citrate buffers (with 150 mM NaCl)
using specific ratios of 0.2 M Na2HPO4 and 0.1 M citrate to achieve a final
pH of 7.5 or pH 6.0, 5.5, and 4.0 for the low-pH studies described below.
Empty-capsid production and purification. Empty capsids of AAV6,
assembled from VP1, VP2, and VP3, were produced in HEK293 cells. A
5-liter suspension culture, at an initial concentration of 1  106 cells/ml,
was transfected with two plasmids, pXX680 (carrying Ad helper genes)
and pXR6 (encoding VP1, VP2, and VP3 of AAV6), for 48 h as previously
described (55). The cell pellet was resuspended in phosphate-buffered
saline (PBS) and purified as described above for the baculovirus-ex-
pressed VLPs.
VLP and empty-capsid secondary-structure analysis. The second-
ary-structure state of the AAV1 VLPs (assembled from VP1, VP2, and
VP3) was analyzed at different pHs and increasing temperatures using
CD. The AAV6 VLPs (assembled either from VP2 and VP3 or from VP1,
VP2, and VP3) and empty capsids (assembled from VP1, VP2, and VP3)
were also analyzed at pH 7.5 by CD. All the CD experiments were carried
out on an Aviv model 410 circular dichroism spectrometer. Preliminary
analysis showed that CD data collection below a wavelength of 200 nm
drastically overloaded the dynode and created large variations in the data
accompanied by large error values. Therefore, all the data were collected at
a wavelength range of 260 to 200 nm. Data were collected with sample
concentrations of 0.4 mg/ml in quartz cuvettes with 350-l volumes at a
1-mm path length. A single scan was collected for every wavelength (total,
61 scans), and results were averaged over a 5-s exposure time. The pH 7.5,
6.0, 5.5, and 4.0 studies were conducted in triplicate with 50 scans per
experimental run at 30°C. Experiments that measured the thermal tran-
sition temperatures of the VLPs were also done in triplicates with CD
spectra collected at a temperature range of 30 to 90°C with three-degree
intervals (21 spectra).
Standard CD deconvolution programs require data collected to at least
190 nm; therefore, these programs could not be used to deconvolute the
data collected between 260 and 200 nm. Thus, an in-house algorithm was
developed by utilizing CD information for pure -helix, -sheet, and
random coil structures of polylysine from data published by Greenfield
and Fasman (56). An array of CD spectra corresponding to theoretical
combinations of -helix, -sheet, and random coil between 0 and 100%
with 10% intervals was generated for comparison to the experimental
observations. To analyze the experimental data, each spectrum was first
scaled to the theoretical CD spectra (by wavelength) and then fitted by a
least-squares approach.
AAV capsid integrity. The AAV1 capsid integrity following tempera-
ture and pH treatment was checked by negative-stain EM studies. Five
microliters of sample was applied to carbon-coated copper grids and in-
cubated for 5 min. The sample drop was wicked (Whatman filter paper)
and washed with double-distilled water (ddH2O), and the grid was nega-
tively stained with 5 l Nano-W (Nanoprobes) for 1 min and examined in
a JEOL 1200 EX transmission electron microscope at a magnification of
50,000.
Computational analysis of the AAV VP sequence and structure. The
ExPASy Compute pI/Mw tool (57) was used to calculate pI values for the
VP1u, VP1/2 common region, and VP3 sequences for the 12 AAV sero-
types characterized to date (5–7). The values obtained were subsequently
used to calculate the pI values for the entire capsids (60 VPs) based on a
VP1:VP2:VP3 ratio of 1:1:10 using an algorithm developed in-house.
Based on an accepted pI value of 5.0 for nucleotides (58), the pI value
was also calculated for capsids packaged with genomic DNA (4.7 kb). To
evaluate the order/disorder potential for the AAV VPs, the PONDR-Fit
program (59) was used to calculate the intrinsic disorder disposition for
the VP1 sequence of AAV1, AAV2, AAV5, and AAV8, selected to repre-
sent the range of sequences similar among the AAVs and for which high-
resolution crystal structures are available (at least for the VP3 common
region) and can be used for validation. Predicted models (a total of five)
for the first 250 amino acids of AAV1 VP comprising the VP1u, the VP1/
VP2 common region, and the first 48 residues of the VP3 common region
were generated using the Robetta full-chain protein structure prediction
server (60). The Coot (61) program was used to superpose the models
onto the available crystal structures of bovine pancreatic phospholipase
A2 (62) (Protein Data Base [PDB] ID, 1BP2) and AAV1 (PDB ID, 3NG9),
using a least-squares-based secondary structure matching (SSM) subrou-
tine, for comparative analysis.
RESULTS
Computational analysis predicts an ordered structure for VP1u
but intrinsic disorder for the VP1/2 common region of the AAV
capsid VP. Five Robetta server models generated for the N-termi-
nal 250 amino acids of AAV1 predicted that the VP1u sequence
(residues 1 to 137), not observed in the crystal structure, contain
several -helical segments connected by loop regions (Fig. 2). The
VP1/2 common region (residues 138 to 202), however, consisted
mainly of random coil (loop) secondary structure (Fig. 2C and D).
A superposition of the best two models onto the bovine pancreatic
phospholipase A2 structure (root mean square deviations
[RMSDs], 3.3 and 2.8 Å) is shown in Fig. 2C. The two dominant
helices that included the PLA2 active site showed a high degree of
overlap between the structures. Superposition of these VP1u
models onto the crystal structure of the AAV1 capsid monomer,
guided by the structures of residues 217 to 250 present in both the
models and the crystal structure, localized the VP1u directly be-
neath the icosahedral 2-fold interface (Fig. 2D) in the capsid inte-
rior.
The PONDR-Fit algorithm predicted an ordered structure for
the VP1u sequence, an intrinsically disordered (threshold value,
0.5 [59]) stretch in the VP1/2 common region (residues 140 to
202) and up to residue 220 in the VP1/VP2/VP3 common se-
quence and an ordered structure for the remainder of the com-
mon VP3 sequence with small stretches of intrinsic disorder
within the previously defined capsid VRs (Fig. 3). The consensus
low-intrinsic-disorder disposition regions predicted for VP3 were
localized to the structurally conserved A-I and A regions
(Fig. 3).
The calculated pI values for the VPs of AAV1 to AAV12 are
plotted in Fig. 4. The VP1u region had a consistent acidic pI value
of 4.8 for all the AAVs. The VP1/2 common region had some
variability in calculated pI value across the AAV serotypes ranging
from 5.2 (AAV11) to 9.8 (AAV7, AAV8, and AAV10). This
variability was likely due to the lower number of amino acids used
for the calculation than that for the VP1u and VP3 sequence
lengths. The average calculated pI value of the VP1/2 common
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region across the serotypes was 7.2. The VP3 sequences had an
average calculated pI value of 6.3. Empty capsids also have a
mean calculated pI value of 6.3 for all the AAVs, likely due to the
high abundance of VP3 in the capsid (1:1:10 for VP1:VP2:VP3).
This value was comparable to the previous experimentally deter-
mined value for AAV1 (63). The accepted pI value for DNA (nu-
cleotides) from the literature is 5.0 (58). Using this information,
the AAV capsids with packaged genomes (4.7 kb) had an aver-
age calculated pI value of 5.9, a difference of 0.4 compared to
empty capsids.
Solution studies reveal an ordered structural state for the
AAV1 and AAV6 VP1u. Intact VLPs or empty capsids were used
in the CD experiments. The CD spectrum of AAV1 VLPs at pH 7.5
and 30°C was dominated by an ordered -helical secondary struc-
ture signal with a deconvoluted helical content of 35 to 45% (Fig.
5; Table 1). Of the 518 VP3 common residues ordered in the AAV1
crystal structure, the largest helical region is the 3-turn conserved
-helix (A, residues 294 to 303; Fig. 1A and 2D), which contrib-
utes 1.9% of the total secondary structure of the ordered VP3
monomer. Two other smaller stretches of helical structure (4 and
5 residues each) are observed in the VP3 monomer structure, ac-
counting for 1.7% of the total secondary structure. These regions
thus account for 3.6% of the -helical content of VP3 and
3.4% of the -helical content of the capsid. Therefore, the ma-
jority of the capsid -helical signal observed in solution must be
due to a region of the capsid VP that was not observed in the
crystal structure, residues 1 to 217. This includes VP1u (residues 1
to 137), the VP1/2 N-terminal common region, and the first 15
N-terminal residues of the VP1/VP2/VP3 common region. How-
ever, given the Robetta models and the PONDR-Fit data described
above, it is most likely that the -helical signal arises from the
VP1u sequence.
In order to observe thermal transitions in the secondary struc-
ture of the VLPs, CD spectra were collected for the AAV1 VLPs
between the temperatures of 30 and 90°C. As the temperature was
increased from 30 to 90°C, the CD spectra for AAV1 showed a loss
of -helical secondary structure at 70°C (Fig. 5), while electron
micrographs showed that the capsids were still intact at a similar
temperature (Fig. 6). This would suggest that the changes seen in
the CD signal were primarily a local denaturation event of the VPs
rather than whole-capsid degradation. In order to measure the
thermal transition temperature for this loss of -helicity, elliptic-
ity values at 208 nm were plotted against temperature for the CD
data collected at different pHs (Fig. 7 and 8). For the data collected
at pH 7.5 and 6.0, two distinct conformational states were ob-
served, and the midpoint between these two states was taken as the
thermal transition temperature (Table 1). At pH 5.5 and 4.0, the
ellipticity values were uniformly low with no obvious transition as
the temperature was increased. This suggests an already transi-
tioned state at the low pHs.
In order to understand the effect of endosomal and lysosomal
pH values on the secondary structural state of the AAV1 VLPs, CD
spectra collected at different pHs,7.5, 6, 5.5, and 4.0, at 30°C were
compared. The spectra obtained at the different pHs showed dif-
ferent secondary structural characteristics (Fig. 8). The AAV1 CD
spectrum at pH 6.0 showed a definite decrease in the degree of
-helicity compared to the spectrum at pH 7.5. This trend contin-
ued at pHs 5.5 and 4.0 with significant reduction in CD signal at
the lowest pH. Electron microscopy images of the capsids at these
acidic pHs showed no loss of integrity, consistent with crystal
structures determined at the different endosomal pHs for AAV1
(Edward Miller and Mavis Agbandje-McKenna, unpublished
data) and AAV8 (54). To determine if the conformational change
observed was reversible, AAV1 VLPs were treated at pH 4.0 and
then buffer exchanged back to pH 7.5 prior to CD data collection.
The -helical signal was restored (Fig. 8). Negative-stain EM con-
firmed that these capsids were also intact (not shown). Thus, the
structural transitions that occur with decrease in pH from 7.5 to
4.0 do not affect the overall capsid integrity and are reversible,
including the restoration of the -helical content at pH 7.5. These
observations suggest that the conformational changes may be
controlled by the differential pI of the VP domains (Fig. 4) and
indicate that a decrease in pH may serve as a mechanism to desta-
bilize the capsid or make it more flexible. The observation that the
capsid integrity was maintained at the low pHs indicates that the
change in CD signal under these conditions must be arising from
a region of the VP that does not participate in capsid assembly,
with VP1u the most likely candidate.
In order to confirm that the AAV1 VLP -helical signal, which
decreases with pH and increasing temperature, is due mostly to
the VP1u region, CD spectra were collected for capsids of the
closely related AAV6 (which differs from AAV1 by 6 amino acids)
lacking the VP1u region. AAV6 was used for these studies because
a construct of AAV1 lacking VP1 is currently not available. CD












FIG 2 Cartoon rendition of VP1u models generated by Robetta. (A and B)
Portions of two models of the VP1/2 sequence showing the predominantly
-helical structure of VP1u (cyan and salmon) and a stretch of the random
loops in the VP1/2 common region (yellow). (C) Superposition of two models
(portions of which are shown in panels A and B) onto bovine pancreatic PLA2
(green) (PDB ID, 1BP2). The structures are superimposed with RMSDs of 3.3
Å and 2.8 Å, respectively. The active-site -helix is conserved in both models.
(D) Superposition of a model generated for AAV1 residues 1 to 250 onto the
AAV1 VP3 crystal structure (residues 218 to 736). Helical regions are shown in
cyan, and -strand regions are shown in red ribbon. The VP regions are indi-
cated, the C position of residue 219 is indicated with a purple sphere, A is
labeled, and the interior and exterior surfaces of the VP are indicated. These
images were generated using PyMOL (DeLano Scientific).
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assembled from VP1, VP2, and VP3 as well as VLPs assembled
from VP2 and VP3 only (Fig. 9). As observed for AAV1, the AAV6
VLP spectra were dominated by the -helical signal. It showed a
significant reduction (50%) in the intensity of the CD signal at
pH 7.5 when VP1 was absent. Significantly, the AAV6 VP1, VP2,
and VP3 VLPs were generated from two baculovirus constructs,
one carrying the gene for VP1 and the other encoding VP2 and
VP3. Thus, the observed decrease in CD signal in the VP2 and VP3
VLPs can be confidently assigned to the lack of VP1. Given the
intrinsic disorder predicted for the VP1/2 overlapping region, the
increased signal for the VP1-, VP2-, and VP3-containing VLPs
and empty capsids can be interpreted as arising from VP1u. The
-helical signal for the VP2 and VP3 VLPs compared to the VP1,
VP2, and VP3 VLPs was reduced by 50% (Fig. 9), while that for
AAV1 incubated at pH 5.5 and 4.0 was reduced by 70% and 80%
(Fig. 8), respectively, compared to its signal at pH 7.5. This is
consistent with a contribution from helical regions within VP3,
for example, A and other smaller stretches of -helix, to the
signal observed at pH 7.5. The CD spectra for the VP1, VP2, and
VP3 VLPs and empty capsids were similar in intensity and shape.
This thus further confirms previous reports that AAV and other
parvovirus capsids assembled in heterogonous systems, such as
the baculovirus/Sf9 system, are identical to those produced in
mammalian systems. A temperature profile for the AAV6 VP1,
VP2, and VP3 VLPs, with data collected between 30 and 90°C,
showed the same trend as for the AAV1 VLPs, with a decrease in
the -helical signal with increasing temperature (data not shown).
DISCUSSION
The exact reasons for the lack of ordered electron density for
VP1u, the VP1/2 N-terminal region, and the first 15 residues of
the VP1/VP2/VP3 common sequence in crystal structures of the
AAVs and other parvovirus capsids are unknown. The PONDR-
Fit (59) program predicted a high level of intrinsic disorder in the
AAV VP1/2-common (residues 138 to 202) and VP1/VP2/VP3
common N-terminal regions (up to 220) and an ordered struc-
tural state for the VP1u. The intrinsic disorder predicted for the
VP1/VP2 common residues and the first 15 residues of VP3
would explain why these residues are not ordered in crystal struc-
tures, besides their low copy numbers not being compatible with
the icosahedral averaging process used during structure determi-
nation. In the case of VP1u, since the VP1/2 common region
VRI   helix     VRII            VRIII                VRIV    VRV VRIV VRVII VRVIII               HI Loop      VRIX        




FIG 3 PONDR-Fit plot of AAV1, AAV2, AAV5, and AAV8 VP1 sequences. The plot shows the disorder disposition (y axis) plotted against the residue number
(x axis). The secondary-structure assignments (blue indicates -strands, and green indicates A) of the crystal structures of these viruses are shown below the x
axis along with the regions designated as being variable (VRs VRI to VRIX, in red) between the AAVs. The residues within the HI loop located on the floor of the
capsid surface depression surrounding the icosahedral 5-fold axis are also indicated. Common regions of intrinsic disorder (disorder disposition of 	0.5) and
order (0.5) are observed for the four serotypes compared, although the degree of disorder differs in the VR regions.
Venkatakrishnan et al.
4978 jvi.asm.org Journal of Virology
would act as a connector, a “flexible hinge,” to the ordered VP1/
VP2/VP3 common residues, the flexibility of the connector may
lead to lack of density for this region in averaged crystal structures.
Consistent with the PONDR-Fit prediction, the Robetta server
produced models with an ordered -helical propensity for the
AAV1 VP1u and loop structure for the VP1/VP2/VP3 common
N-terminal regions. Significantly, the location of VP1u under the
icosahedral 2-fold axis following the superposition of the Robetta
models onto the AAV1 crystal structure was consistent with pre-
vious cryo-EM studies reporting density globules in this region
predicted to be VP1u and not observed in capsids assembled with
only VP2 and VP3 (27, 64).
The CD experiments served as a method to confirm that there
is a significant amount of detectable ordered -helical region in
the AAV1 capsid that is likely attributable to the VP1u. This was
confirmed using AAV6 VLPs and empty capsids that showed that
a substantial amount of -helical CD signal can be attributed to
the VP1u region (Fig. 9). Previous reports show PLA2 protein
structures from bovine pancreas (62), snake (65), and bee (66)
venom to be primarily -helical. Thus, since VP1u also contains a
PLA2 domain, it is perhaps not surprising that an ordered -heli-
cal propensity is predicted for it. The -helical content of the
AAV1 capsid, assuming 5 VP1s, 5 VP2s, and 50 VP3s, is 4.5%,
with the VP1u model helices accounting for 1.1%, the VP1/
VP2/VP3 common A accounting for 1.9%, and two small
stretches of helical structure in the loops between the -strands
accounting for the remainder. These helical secondary structure
percentages are much lower than the helical content estimated
from the CD data for the AAV1 capsid at pH 7.5 and lower (Table
1). However, high estimates of helical content based on deconvo-
luted CD spectra are common due to the fact that the spectra are
more sensitive to -helical than to beta or random coil secondary
structural elements. The sensitivity of CD spectra to -helical re-
gions was evident in the AAV6 VLP comparison, with the VP2 and
VP3 VLP spectra showing a 50% decrease in the CD signal com-
pared to the VP1, VP2, and VP3 VLPs, while VP1u should be
contributing only approximately a quarter of the CD signal based
on the percentages above. If only the VP1u models are considered,
their average -helical content is 53% when folded. A 50% con-
tribution from this region to the CD signal would close the gap
FIG 5 Representative CD spectra of AAV1 VLPs at different temperatures. A
clear -helical propensity can be seen for AAV1. This helical signal (proposed
to be due mostly to VP1u) is lost as temperature increases: 30°C (blue), 50°C
(lime green), 60°C (red), 65°C (navy blue), 70°C (orange), and 75°C (green).
TABLE 1 Percentage of -helicity and transition temperatures for






7.5 35–45 72 
 3




a Values based on triplicate experiments; ID, indeterminate value.
FIG 4 Calculated pI values for AAV1 to AAV12. The histogram of the pI values for the AAV serotypes shows that different capsid sequences have different
electrostatic properties. The VP1u (blue) pI values are 1 unit lower than the average pI values of VP3 (green) and the whole (net) capsid (purple). The VP1/2
common region (red) shows a variable pI among the different serotypes.
AAV VP1u Dynamics
May 2013 Volume 87 Number 9 jvi.asm.org 4979
between the percentages deconvoluted from the spectra collected
at pH 7.5 and 6.0 and those calculated based on the VP3 structure
and VP1u models. These CD data thus represent the first experi-
mental documentation of a pH-induced change in -helical sec-
ondary structure in any parvovirus, which is predicted to be due to
VP1u structural transitions.
Previous studies have shown that heating the AAV capsid to a
temperature of 70°C results in the irreversible externalization of
the VP1u region (44, 64). While high temperature may not be the
biological cause for VP1u exposure during the infective pathway
of the virus, this study shows that exposure of the capsid to pHs
that mimic endosomal compartments results in structural
changes in the VP1u similar to those seen at high temperatures.
The negative-stain EM at different temperatures and pHs and
crystal structure data for AAV1 (Edward Miller and Mavis Ag-
bandje-McKenna, unpublished) and AAV8 (54) showed that the
capsid integrity was intact and the mostly -strand structure of the
VP3 common region was unperturbed by pH, respectively. The
conserved A structure is also maintained in these low-pH struc-
tures. Thus, the loss of the -helical signal at high temperature
(70°C) (Fig. 5) and low pH (5.5 and 4.0) is assumed to represent
the unfolding of the secondary structure of the VP1u and is pre-
dicted to have a role in the externalization process. This may ex-
plain how high temperatures are able to induce exposure of the
VP1u, by inducing first the unfolding of the VP1u region and then
its externalization. While a decrease in pH (to 5.0) has not been
shown to induce significant capsid surface exposure of VP1u (44),
this study shows that there is a pH-induced structural change that
takes place in the capsid. It is possible that previous reports of the
inability of pH changes to induce VP1u externalization in vitro,
based on antibody assays, were affected by altered antibody bind-
ing ability at low pHs. The goal of this study was not to document
externalization of VP1u but rather to document the VP dynamics
that could facilitate such a process.
The pH-induced unfolding of VP1u would be an important
step in the externalization process in addition to other biological
or chemical factors. A factor that may contribute to VP1u unfold-
ing relative to the other VP regions and subsequent externaliza-
FIG 6 Electron micrographs of the AAV1 VLPs. At the different temperatures and pHs used for the CD experiments, the capsids are still intact. Only when heated
to 95°C do the capsids show complete denaturation. The images were collected at a magnification of 50,000. RT, room temperature.
FIG 7 Temperature transition curves for AAV1 VLPs at different pHs based on CD signals at 208 nm. Plots are shown for pH 7.5 (dark blue), pH 6.0 (orange),
pH 5.5 (yellow), and pH 4.0 (green). mdeg, millidegrees.
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tion is its local low pI value, which is lower than those of the other
capsid VP regions and the overall capsid, including the packaged
genome. An analysis of the calculated pI values of different capsid
regions for AAV serotypes 1 to 12 showed that VP1u has an acidic
character, with pI values for all the AAVs of 4.8. The pI for the
VP1/2 common region showed more variability, with value ranges
from 5.2 to 9.8 across the 12 serotypes, but the mean value
(7.2) was more basic than the VP3 sequence/capsid at 6.3. The
VP3 and net capsid pI values at 6.3 would indicate that they would
be in a zwitterionic state under early-to-late endosomal pHs, 5.5
to 6.5, although at pH 5.5 residues in the capsid interior, including
histidines observed to contact ordered DNA (54), would become
protonated while VP1u and DNA, at pIs of 4.8 and 5.0, respec-
tively, would still be negatively charged. This difference might be a
determinant factor of the VP1u-specific structural changes at the
low pHs of the late endosome and lysosome, while the capsid itself,
assembled from the VP3 common VP region, does not undergo
secondary structure changes. The observed decrease in CD signal,
attributed to VP1u unfolding, starts to occur at pH 5.5 and is
slightly further reduced when the pH is dropped to 4.0 (Fig. 8). It
is thus possible that charge-charge repulsion between the interior
capsid residues and VP1u and the DNA as the environmental pH
decreases may play a role in triggering VP1u unfolding and exter-
nalization. Given the large variability in the calculated pI values
for the VP1/VP2 common region across the AAV serotype, it is
difficult to predict how the charge state of this domain contributes
to VP1u externalization. However, its flexibility, based on its pre-
dicted intrinsic disorder state, would be required to permit a large
motion of VP1u for extrusion from the capsid.
Given that VP1u is ordered in solution while located inside the
capsid, it becomes more difficult to visualize the process of exter-
nalization while the capsid stays intact. Biochemical studies of
AAV trafficking suggest that the VP1u and VP1/VP2 common N
termini become externalized, from an intact capsid, in the endo-
somal compartment prior to entry into the cytoplasm (44). Mu-
tagenesis studies altering residues at the base of and within the
5-fold channel formed by symmetry-related DE loops have sug-
gested this pore as the route for VP1u externalization (45). How-
ever, in structural studies of AAV8 capsids at different pHs, only a
minor increase in diameter, 1.0 Å, was observed at the top of this
channel when the pH was shifted from 7.5 to 4.0 (54). For AAV1,
the top of the pore is 1.5 Å wider at pH 4.0 than at pH 7.5
(Edward Miller and Mavis Agbandje-McKenna, unpublished). In
both viruses, these differences are not propagated down into the
channel, which is 20 Å in diameter at the top and 12 Å at its
base. This is too narrow to allow a folded VP1u to be threaded
through, consistent with reports that pH alone likely does not lead
to VP1u externalization (44). In a more recent study, it was re-
ported that formation of dityrosine adducts across the 2-fold axis,
which generated cross-linked dimers, prevented externalization of
the VP1u (67). This observation led to the suggestion that capsid
dynamics at the 2-fold axis may also be involved in VP1u exter-
nalization. However, as with the 5-fold axis, the low-pH structures
of AAV1 and AAV8 showed no major structural rearrangements
at the 2-fold axis that would enable VP1u externalization. Only
side chain conformational changes are observed. These structural
observations thus invoke the likely involvement of other factors in
this process. In a study by Levy et al. on AAV2 complexed with
heparin, a structural change was reported at the 5-fold channel in
the presence of this cell surface glycan receptor (68). The channel
was reported to open in an iris-like rotation of the ring of residues
leading to the widening of the top. However, the widening was also
not enough to allow a folded VP1u to be externalized. Thus, it is
possible that receptor attachment or other cellular interactions or
conditions, combined with endosomal acidification, may precede
the unfolding of VP1u in the context of endosomal trafficking of
the capsid. It is also possible that the completely unfolded VP1u
can thread through an unexpanded 5-fold channel.
The CD data can be combined with models generated by Ro-
betta for the VP1u and VP1/2 sequence and confirmatory struc-
ture prediction from the PONDR-Fit algorithm to generate a pH-
induced unfolding, externalization through the 5-fold channel,
and refolding model for VP1u and VP1/2 (Fig. 10). In this model,
VP1u, with a reversible unfolding/folding phenotype (Fig. 8),
would adopt a native structure following externalization into a
favorable environment. However, it is difficult to reconcile the
FIG 9 Representative CD spectra of AAV6 VLPs and empty capsids at pH 7.5.
Plots are shown for VLPs and empty capsids assembled from VP1, VP2, and
VP3 (cyan and blue) and VLPs assembled from VP2 and VP3 only (red). A
decrease in -helical propensity (50%) is seen in the VLPs assembled from
VP2 and VP3 only.
FIG 8 Representative CD spectra of AAV1 VLPs at the different pHs collected
at 25°C. Plots are shown for pH 7.5 (dark blue), pH 6.0 (orange), pH 5.5
(yellow), pH 4.0 (green), and pH 4.0 to 7.5 (blue). A loss of secondary structure
is seen with decrease in pH. This signal is restored when the pH 4.0 sample is
transitioned back to pH 7.5.
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externalization of an unfolded VP1u in the late endosome or
lysosome with its PLA2 function to enable escape from these cel-
lular compartments when this activity is reported to have a pH
optimum of 7.0 (69). Reports on AAV2 trafficking have indicated
that capsids can escape from early endosomes (43, 44). At this pH
(6.0), the VP1u would be mostly folded with some PLA2 activity,
although it is not obvious how it would escape from its interior
location, inside the capsid. Under late endosomal conditions, pH
5.5, it is possible that VP1u is only partially unfolded, retains
some of its function, and on contact with its substrate on the lipid
membrane, becomes fully functional. The same could be true for
escape at pH 4.0, although functionality would be expected to be
more severely impaired at this pH. These possibilities require fur-
ther study.
In summary, AAV1 and AAV6 VP1u are structurally ordered
in an -helical conformation inside the capsid. This secondary
structure is reversibly unfolded/refolded in a pH-dependent man-
ner by decrease in pH from 7.5 to 4.0 and increase back to 7.5. A
predicted intrinsic disorder in the VP1/2 common region and the
differential charge states of the VP1u and the VP3 capsid likely
impart the flexibility and repulsion, respectively, required to per-
mit the externalization of VP1u through the 5-fold channel fol-
lowing low-pH-induced unfolding in the low pH of the late endo-
somal (5.5) or lysosomal (4.0) compartments. It is also possible
that the 2-fold axis plays a role in this externalization process. This
study provides insights into the potential mechanism of capsid VP
rearrangements in preparation for endosomal escape of the AAV
capsid.
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